Pneumocystis jirovecii Pneumonia in Patients Without HIV, Transplant, or Cancer: Missed Opportunities for Prevention
Most patients in our cohort did not receive PJP prophylaxis, and outcomes were poor with high mortality rates. Standardized risk stratification and prophylaxis protocols are needed to improve outcomes.
Authors
- Gregory J. Challener (ORCID: https://orcid.org/0000-0002-2844-4661)
- Gabriel E. Ortiz Jaimes
- Mohamad El Labban (ORCID: https://orcid.org/0000-0003-4244-9204)
- Jay Hoon Ryu (ORCID: https://orcid.org/0000-0002-9576-2272)
- Misbah Baqir (ORCID: https://orcid.org/0000-0002-5632-8131)
- Sarah B. Leung
- Amjad Kanj (ORCID: https://orcid.org/0000-0003-0470-3603)
Institutions
- Mayo Clinic (US)
- Massachusetts General Hospital (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1097/rhu.0000000000002279
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00